Difference between revisions of "Task 8: Sequence-based mutation analysis"
(→Mutation analysis results) |
(→Mutation analysis results) |
||
Line 69: | Line 69: | ||
| || Val53Met || brached chain, nonpolar, neutral charge || sulfur containing, nonpolar, neutral charge|| align="center" | [[File:val53met.png|center|thumb|200px| Val53Met mutation with valine in yellow and methionine in red.]] || || || || || || || || || |
| || Val53Met || brached chain, nonpolar, neutral charge || sulfur containing, nonpolar, neutral charge|| align="center" | [[File:val53met.png|center|thumb|200px| Val53Met mutation with valine in yellow and methionine in red.]] || || || || || || || || || |
||
|- |
|- |
||
− | | || His63Asp || aromatic ring, basic polar, mainly neutral charge || acidic polar, negative charge ||[[File: |
+ | | || His63Asp || aromatic ring, basic polar, mainly neutral charge || acidic polar, negative charge ||[[File:his63asp.png|center|thumb|200px| His63Asp mutation with histidine in yellow and aspartic acid in red.]] || || || || || || || || || |
|- |
|- |
||
| || Arg67His || || || || || || || || || || || || |
| || Arg67His || || || || || || || || || || || || |
Revision as of 18:56, 22 August 2013
<css> table.colBasic2 { margin-left: auto; margin-right: auto; border: 2px solid black; border-collapse:collapse; width: 90%; }
.colBasic2 th,td { padding: 3px; border: 2px solid black; }
.colBasic2 td { text-align:left; }
.colBasic2 tr th { background-color:#efefef; color: black;} .colBasic2 tr:first-child th { background-color:#adceff; color:black;}
</css>
Mutation selection
<figtable id="mutations">
mutations | ||
---|---|---|
nucleotide change | amino acid change | |
Val53Met | ||
His63Asp | ||
Arg67His | ||
Met97Ile | ||
Asn130Ser | ||
Glu168Gln | ||
Leu183Pro | ||
Thr217Ile | ||
Cys282Tyr | ||
Arg330Met |
</figtable>
Mutation analysis results
<figtable id="summary">
reference | mutation | pyhsicochemical properties | strucural properties | conservation | prediction programms | consensus | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
from | to | pymol visualisation | secondary structure | substitution matrix | PSSM | MSA | SIFT | Polyphen2 | MutationTaster | SNAP | |||
Val53Met | brached chain, nonpolar, neutral charge | sulfur containing, nonpolar, neutral charge | |||||||||||
His63Asp | aromatic ring, basic polar, mainly neutral charge | acidic polar, negative charge | |||||||||||
Arg67His | |||||||||||||
Met97Ile | |||||||||||||
Asn130Ser | |||||||||||||
Glu168Gln | |||||||||||||
Leu183Pro | |||||||||||||
Thr217Ile | |||||||||||||
Cys282Tyr | |||||||||||||
Arg330Met | Could not be visualized because this resdiue is not contained in the the pdb structure. |
</figtable>
All results from the mutation analysis are summarised in <xr id="summary"/>. Physicochemical properties are specified as characteristics of the aa, side chain polarity and charge.
Val53Met
The main effect of the change from valine to methonine is mainly due to the structure, because both aa are nonpolar and neutral. Methionine is linear and valine has a branched structure. As can be seen in the picture, this could lead to clashes with the alpha helix above the methionine.
His63Asp
h
This mutation is very likely disease causing, because the basic aa histidine is replaced by the acidic aspartic acid. Besides, histidine is mainly neutral whereas the aspartic acid is negatively charged.